Results 41 to 50 of about 1,581 (183)
Senotherapeutics for HIV and aging
Purpose of review To summarize the state of chronic, treated HIV infection and its contribution to accelerated aging, and to evaluate recent research relevant to the study and treatment of aging and senescence. Recent findings Chronic treated HIV-1 infection is associated with ...
Matthew A, Szaniawski, Adam M, Spivak
openaire +3 more sources
Meeting Report: Aging Research and Drug Discovery [PDF]
Aging is the single largest risk factor for most chronic diseases, and thus possesses large socioeconomic interest to continuously aging societies. Consequently, the field of aging research is expanding alongside a growing focus from the industry and ...
Ai, Ruixue +77 more
core +5 more sources
Objective: The field of targeting cellular senescence with drug candidates to address age-related comorbidities has witnessed a notable surge of interest and research and development.
Li Ping Wong +7 more
doaj +1 more source
Dasatinib Attenuates Fibrosis in Keloids by Decreasing Senescent Cell Burden
Keloids are skin tumours caused by aberrant growth of dermal fibroblasts. Cellular senescence contributes to aging and various pathological conditions, including cancer, atherosclerosis, and fibrotic diseases.
Claudia C. Darmawan +5 more
doaj +1 more source
Senotherapeutics and Their Molecular Mechanism for Improving Aging
Aging is defined as physiological dysfunction of the body and a key risk factor for human diseases. During the aging process, cellular senescence occurs in response to various extrinsic and intrinsic factors such as radiation-induced DNA damage, the activation of oncogenes, and oxidative stress.
Park, Jooho, Shin, Dong Wook
openaire +2 more sources
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Cellular senescence is a state of irreversible growth arrest with profound phenotypic changes, including the senescence-associated secretory phenotype (SASP).
Amit K. Dey +7 more
doaj +1 more source
Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis
Cellular senescence is one of the important mechanisms of skin aging. In a recent study, we have shown that in patients with dermatoporosis, an extreme senescence condition of the skin, cells positive for p16Ink4a, a biomarker of senescence, were significantly increased in the epidermis.
Kaya, Aysin +2 more
openaire +4 more sources
Moving from an “anti-aging” paradigm toward the concept of “disease-free aging”: the role of senolytics in modern medicine [PDF]
Senescent cells increase with aging and are related to the promotion of inflammation and neoplasia through the senescence-associated secretory phenotype (SASP). These cells are closely related to the biological aging process and, most importantly, to age-
Ivan Aprahamian +2 more
doaj +1 more source
Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer [PDF]
Background: Prostate cancer (PCa) is an age-related malignancy in men with a high incidence rate. PCa treatments face many obstacles due to cancer cell resistance and many bypassing mechanisms to escape therapy.
Atri Roozbahani, Golnaz +3 more
core +2 more sources
Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic lung disease characterized by progressive scarring of the lung tissue, leading to respiratory failure. There is no cure for IPF, and current anti-fibrotic treatments modestly arrest its further progression. IPF prevalence and incidence increase with age, which is a recognized risk factor.
Wolfgang, Merkt +3 more
openaire +3 more sources

